Location: New York, NY
CIK: 0001825034 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $299M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV PHARMACEUTICALS INC | 4,179,416 | $137M | 46.0% | $39.23 | +0.5% | COM | 69353Y103 |
| — | NGM BIOPHARMACEUTICALS INC | 1,493,349 | $43.41M | 14.5% | $30.30 | — | COM | 62921N105 |
| ORIC | ORIC PHARMACEUTICALS INC | 996,734 | $24.42M | 8.2% | $28.69 | +10.1% | COM | 68622P109 |
| ALEC | ALECTOR INC | 980,894 | $19.75M | 6.6% | $12.43 | +44.3% | COM | 014442107 |
| DNLI | DENALI THERAPEUTICS INC | 323,749 | $18.49M | 6.2% | $60.45 | +10.7% | COM | 24823R105 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,261,261 | $16.62M | 5.6% | $19.16 | -14.5% | COM | 344174107 |
| — | RAPT THERAPEUTICS INC | 735,801 | $16.34M | 5.5% | $19.75 | — | COM | 75382E109 |
| — | CONSTELLATION PHARMCETICLS I | 554,325 | $12.97M | 4.3% | $28.80 | — | COM | 210373106 |
| FFBC | FIRST FINL BANCORP OH | 173,576 | $4.166M | 1.4% | $12.77 | +42.3% | COM | 320209109 |
| BEAM | BEAM THERAPEUTICS INC | 31,131 | $2.492M | 0.8% | $95.13 | 0.0% | COM | 07373V105 |
| VIR | VIR BIOTECHNOLOGY INC | 25,864 | $1.326M | 0.4% | $53.89 | 0.0% | COM | 92764N102 |
| PDD | PINDUODUO INC | 8,174 | $1.094M | 0.4% | $133.84 | — | SPONSORED ADS | 722304102 |
| — | RUBIUS THERAPEUTICS INC | 12,791 | $339K | 0.1% | $26.50 | — | COM | 78116T103 |